Replies to post #221616 on Biotech Values

[dangerM]

... so that was a relatively short speech*, but he mentioned a drug against blindness (=Eylea/REGN?) and osteoporosis (=Prolia/AMGN and Forteo/LLY?) as examples.

I guess the most interesting part will be the most favoured nations approach ... to what share will it mean an increase in the drug prices abroad as well. Phew, no idea.

dM





*one really has to wind within the archived live stream to find it
https://www.youtube.com/user/whitehouse/videos, alternatively it'll be among the regular videos soon, I guess

[TwoNE1]

Comparison of U.S. and International Prices for Top Medicare Part B Drugs by Total Expenditures

You can download the report here:
https://aspe.hhs.gov/pdf-report/comparison-us-and-international-prices-top-medicare-part-b-drugs-total-expenditures

The following drugs are mentioned:
Alimta
Aranesp
Avastin
Cimzia
Eligard/ Multiple Products
Eylea
Gammagard
Gamunex-c/gammaked
Herceptin
Kadcyla
Keytruda
Lucentis
Neulasta
Opdivo
Orencia
Privigen
Prolia/Xgeva
Remicade
Rituxan
Sandostatin LAR
Soliris
Treanda
Tysabri
Velcade
Xolair
Yervoy
Zaltrap